"I shouldn't need a Rosetta Stone to understand your notes." -- Prashant Tailor, MD, of the University of California Los ...

SAN DIEGO -- Biomarker and cognitive data supported treatment with the anti-amyloid agent lecanemab (Leqembi) for up to 36 ...

The consequences are rippling across every domain of science and medicine, leaving the academic community grappling with how ...

But after just 4 months behind bars, John Estin Davis walked free. President Donald Trump commuted Davis' sentence in the ...

A second unvaccinated school-age child in West Texas died from a measles-related illness, a hospital spokesman confirmed ...

Some raise concerns about disruption in services ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

The U.S. now has more than double the number of measles cases it saw in all of 2024, with Texas reporting another large jump ...

Ten drugs were classified as low or no added therapeutic benefit compared with alternatives, accounting for $6.7 billion in ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the federal ...

"One of the conversations I heard in the hallway was, 'What's going to happen to my research, my data? This is data that [is ...